Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

CCI-779 in brain and pediatric tumors

Nov. 27, 2003

Promising results reported for DX-8951f in pediatric cancer

Nov. 27, 2003

Assessment of two treatment schedules for OSI-7836 in cancer patients

Nov. 27, 2003

Preliminary results for motexafin gadolinium combined with doxorubicin in solid tumors

Nov. 27, 2003

Good safety profile found for LE-SN-38 in advanced cancer patients

Nov. 27, 2003

MLN-2704 potentially effective against bone metastases in prostate cancer

Nov. 27, 2003

Low systemic toxicity reported for NLCQ-1 in rats

Nov. 27, 2003

ImClone seeks approval for Erbitux in Canada

Nov. 26, 2003

Urethane derivative of pladienolide B with enhanced antitumor activity

Nov. 26, 2003

European CPMP hands down positive opinion for Faslodex

Nov. 26, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 5, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.